therapeutic role of exercise in treating hypertension
TRANSCRIPT
Educational Objectives
To explain the acute blood pressure response to exercise
To list the mechanisms by which exercise may improve hypertension
To apply exercise guidelines in treating hypertension
To prescribe appropriate drug therapy for active hypertensive patients
Overview of Hypertension
High BP is a risk factor for stroke, CHF, angina, renal failure, …
Hypertension clusters with hyperlipidemia, diabetes and obesity
Drugs have been effective in treating high BP but because of their side effects and cost, non-pharmacologic alternatives are attractive
Classification of Blood Pressure
Blood Pressure Category Systolic Diastolic
Optimal <120 <80
Normal <130 <85
High Normal 130-139 85-89
Hypertension
Stage 1 (Mild) 140-159 90-99
Stage 2 (Moderate) 160-179 100-109
Stage 3 (Severe) > 180 > 110
Pathophysiology of Hypertension
High blood pressure is also associated with obesity, salt intake, low potassium intake, physical inactivity, heavy alcohol use and psychological stress
Intra-abdominal fat and hyperinsulinemia may play a role in the pathogenesis of hypertension
Prevalence of Other Risk Factors With Hypertension
Risk Factor Percent
Smoking 35
LDL Cholesterol >140 mg/dl 40
HDL Cholesterol < 40 mg/dl 25
Obesity 40
Diabetes 15
Hyperinsulinemia 50
Sedentary lifestyle >50
Cardiovascular Consequences of Hypertension
Individuals with BP > 160/95 have CAD, PVD & stroke that is 3X higher than normal
HTN may lead to retinopathy and nephropathy
HTN is also associated with subclinical changes in the brain and thickening and stiffening of small blood vessels
Cardiovascular Consequences
of Hypertension
Increased cardiac afterload leads to left ventricular hypertrophy and reduced early diastolic filling
Increased LV mass is positively associated with CV morbidity and mortality independent of other risk factors
High BP also promotes coronary artery calcification, a predictor of sudden death
Hypertension & CVD Outcomes
Increased BP has a positive and continuous association with CV events
Within DBP range of 70-110 mm Hg, there is no threshold below which lower BP does not reduce stroke and CVD risk
A 15/6 mm Hg BP reduction reduced stroke by 34% and CHD by 19% over 5 years
Lifestyle Changes for Hypertension
Reduce excess body weight Reduce dietary sodium to < 2.4 gms/dayMaintain adequate dietary intake of potassium,
calcium and magnesiumExercise moderately each dayEngage in meditation or relaxation dailyCessation of smoking
Blood Pressure classification
Blood Pressure Stage (mm Hg)
Risk Group A No major risk factors No TOD/CCD
Risk Group B At least one major risk factor, not including DM No TOD/CCD
Risk Group C TOD/CCD and/or DM, with or without other risk factors
High-Normal BP 130-139/85-89
Lifestyle Modification
Lifestyle Modification
Medication Lifestyle Modification
Stage 1 HTN 140-159/90-99
Lifestyle Modification (up to 12 mo)
Lifestyle Modification (up to 6 mo)
Medication Lifestyle Modification
Stage 2,3 HTN 160/100
Medication Lifestyle Modification
Medication Lifestyle Modification
Medication Lifestyle Modification
Medical Therapy and Implications for Exercise Training
Pharmacologic and nonpharmocologic treatment can reduce morbidity
Some antihypertensive agents have side-effects and some worsen other risk factors
Exercise and diet improve multiple risk factors with virtually no side-effects
Exercise may reduce or eliminate the need for antihypertensive medications
Exaggerated BP Response to Exercise
Among normotensive men who had an exercise test between 1971-1982, those who developed HTN in 1986 were 2.4 times more likely to have had an exaggerated BP response to exercise
Exaggerated BP response increased future hypertension risk by 300% after adjusting for all other risk factors
Exaggerated BP Response to Exercise
Exaggerated BP was change from rest in SBP >60 mm Hg at 6 METs; SBP > 70 mm Hg at 8 METs; DBP > 10 mm Hg at any workload.
Subjects in CARDIA study with exaggerated exercise BP were 1.7 times more likely to develop HTN 5 years later
J Clin Epidemiol 51 (1): 1998
NIH Consensus Conference on Physical Activity and CV Health (1995)
Review of 47 studies of exercise and HTN70% of exercise groups decreased SBP by an
avg. of 10.5 mm Hg from 15478% of subjects decreased DBP by an avg. of
8.6 mm Hg from 98Only 1 study showed increased BP w/ EXBeneficial responses are 80 times more
frequent than negative responsesHagberg, J., et.al., NIH, 1995: 69-71
The Pedometer
a small device worn at the waist that counts steps
used successfully in obesity studies
Possible Mechanisms of BP Reduction with Exercise
Reduced visceral fat independent of changes in body weight or BMI
Altered renal function to increase elimination of sodium leading to reduce fluid volume
Anthropomorphic parameters may not be primary mechansims in causing HTN
Possible Mechanisms of BP Reduction with Exercise
Lower cardiac output and peripheral vascular resistance at rest and submaximal exercise Decreased HR Decreased sympathetic and increased
parasympathetic tone Lower blood catecholamines and plasma
renin activity
Exercise Prescriptions for Patients With Borderline-to-Moderate Hypertension
Patient evaluation
Look for lipid disorders, DM, retinopathy, neuropathy, PVD, renal insufficiency, LV dysfunction, silent MI/ischemia osteoarthritis, osteoporosis
Exercise testing GXT with modified Naughton protocol, R/O asymptomatic ischemic CAD, radionuclide
Exercise type Aerobic, low-impact activities: walking, biking, swimming, tai chi, stepper, treadmill walking
Exercise Prescriptions for Patients With Borderline-to-Moderate Hypertension
Frequency 5 days/week as a minimum
Intensity Start at 50-60% maximum HRR & slowly increase to 70%; within 6 weeks work at 85% HRR or from 50-90% of maximal heart rate
Duration Start with 20-30 min/day of continuous activity for first 3 wk, then 30-45 min/day for next 4-6 wk, and 60 min/day as maintenance
Exercise Prescriptions for Patients With Borderline-to-Moderate Hypertension
Excessive rises in blood pressure should be avoided during exercise (SBP > 230 mm Hg; DBP > 110 mm Hg). Restrictions on participation in vigorous exercise should be placed on patients with left ventricular hypertrophy.
Weight Training
Resistive exercise produces the most striking increases in BP
Resistive exercise results in less of a HR increase compared with aerobic exercise and as a result the “rate pressure product” may be less than aerobic exercise
Assessment of BP response by handgrip should be considered in patients w/ HTN
Growing evidence that resistive training may be of value for controlling BP
Beta-blocker therapy and exercise
Non-selective Beta-blockers may increase a patient’s disposition to exertional hyperthermia. So patients should adhere strictly to guidelines for fluid replacement
Patients should use fluid replacement drinks with low concentrations of K+ to avoid the risk of hypokalemia
Gordon, N.F., Am J Cardiol 55: 74-78,1985
SUMMARY
Physical activity has a therapeutic role in the treatment of hypertension
No consistent relationship between reduced weight and lower BP
Exercise at lower intensities is effective in treating mild to moderate hypertension
Exercise testing may help identify exaggerated BP responses to exercise
SUMMARY
Exercise prescription for HTN should be based on medical hx and risk factor status
Exercise prescription should be adapted to antihypertensive medications that may affect exercise HR, BP & performance
Incorporating resistive training into the exercise prescription may be of value for controlling blood pressure
References
Chintanadilok, J., Exercise in Treating Hypertension, PhysSports Med 30: 11-23, 2002
Urata, H., Antihypertensive and Volume-Depleting Effects of Mild Exercise on Essential Hypertension, Hypertension 9: 245-52, 1987.
Tanabe, Y., Changes in Serum Concentration of Taurine and Other Amino Acids in Clinical Antihypertensive Exercise Therapy, Clin and Exper Hyper A11: 149-165, 1989.
American College of Sports Medicine, Physical Activity, Physical Fitness and Hypertension, Med Sci Sports Exerc 25: i - x , 1993.
ACSM’s Resource Manual for Guidelines for Exercise Testing and Prescription, Baltimore, Williams & Wilkins, p. 275-280, 1998.